20.500.12556/DiRROS-31034 Pojavnost benzodiazepinov v skupini novih psihoaktivnih snovi v Evropi med leti 2008 in 2024 The prevalence of benzodiazepines in the group of new psychoactive substances in Europe between 2008 and 2024 Nove psihoaktivne snovi so sintetične ali naravne snovi, ki posnemajo učinke prepovedanih drog, a zaradi hitro spreminjajoče se sestave ostajajo nenadzorovane. Mednje sodijo tudi benzodiazepini, pomembna skupina zdravil, ki se v obliki novih analogov pojavljajo kot nove psihoaktivne snovi. Članek prikazuje pojavnost, uporabo in zdravstvena tveganja benzodiazepinov kot psihoaktivne nove snovi v Evropi med 2008 in 2024 na podlagi Evropske zbirke podatkov o novih drogah. Identificiranih je bilo 38 novih benzodiazepinov, največ (24) med leti 2014 in 2018, nato je število upadlo. Največ prijav prihaja iz Švedske, sledijo Nemčija in druge skandinavske države. Slovenija je med vodilnimi: zaznani so bili trije novi benzodiazepini in skupaj 14 različnih (37 % vseh), od katerih jih je osem v skupini I prepovedanih snovi. Večina zasegov vključuje tablete in praške, pogosto v kombinacijah, kar povečuje tveganje smrti. Leta 2020 so bili prisotni v polovici smrtnih primerov zaradi drog v Sloveniji, delež pa upada. Zloraba njihovih analogov kot novih psiho aktivnih snovi povzroča resne posledice, zato je spremljanje nujno. New psychoactive substances are synthetic or natural substances that mimic the effects of illicit drugs but remain uncontrolled due to rapidly changing composition. These include benzodiazepines, an important group of medicines that appear as new psychoactive substances in the form of new analogues. This article presents the prevalence, use, and health risks of benzodiazepines as new psychoactive substances in Europe between 2008 and 2024, based on the European Database on New Drugs. In total, 38 new benzodiazepines were identified, most (24) between 2014 and 2018, followed by a decline. Most reports originate from Sweden, followed by Germany and other Scandinavian countries. Slovenia is among the leading countries: three new benzodiazepines were detected and 14 different ones in total (37% of all), eight of which are classified in Group I of prohibited substances. Most seizures involve tablets and powders, often in combinations, increasing the risk of death. In 2020, they were present in half of Slovenia’s drug-related deaths, though the proportion is decreasing. Monitoring remains essential. Agencija Evropske unije za droge benzodiazepini nove psihoaktivne snovi zloraba abuse benzodiazepines European Union Drugs Agency new psychoactive substances true false true Slovenski jezik Angleški jezik Neznano 2026-07-10 11:53:22 2026-07-10 11:53:23 2026-07-11 03:51:13 0000-00-00 00:00:00 2026 0 0 Opis vira z dne 26. 3. 2026; Nasl. z nasl. zaslona; str. 3-12 št. 1 Letn. 77 marec 2026 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 2026-03-01 615.214 2536-4316 273089027 majar.pdf majar.pdf 1 98A734B0483E154901C0668A40C17747 7d709815756f342b9653f0eef0c8f91054aef618f1e55cd41bf6f9502a0955ae 30b1d0da-7c45-11f1-b663-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=47811 Slovensko farmacevtsko društvo 0 0 0